FPGA Implementations of the Round Two SHA-3 Candidates

The second round of the NIST-run public competition is underway to find a new hash algorithm(s) for inclusion in the NIST Secure Hash Standard (SHA-3). This paper presents the full implementations of all of the second round candidates in hardware with all of their variants. In order to determine their computational efficiency, an important aspect in NIST's round two evaluation criteria, this paper gives an area/speed comparison of each design both with and without a hardware interface, thereby giving an overall impression of their performance in resource constrained and resource abundant environments. The implementation results are provided for a Virtex-5 FPGA device. The efficiency of the architectures for the hash functions are compared in terms of throughput per unit area. To the best of the authors' knowledge, this is the first work to date to present hardware designs which test for all message digest sizes (224, 256, 384, 512), and also the only work to include the padding as part of the hardware for the SHA-3 hash functions.

Isolation, pharmacology and gene organization of KPSFVRFamide: A neuropeptide from Caenorhabditis elegans

To date, 53 peptides with C-terminal RFamides have been identified by the genome sequencing project in the nematode, Caenorhabditis elegans. In this study the FMRFamide-related peptide (FaRP) KPSFVRFamide (879.90 Da [MH](+)) was structurally characterized from extracts of the nematode, Caenorhabditis elegans. Two copies of KPSFVRFamide are encoded by a gene designated flp-9. RT-PCR identified a single cDNA product which was confirmed as flp-9 by sequence determination. Flp-9 cDNA was isolated from larval stages of C. elegans but was not detected-in adult worms, indicating that its expression is may be developmentally regulated. KPSFVRFamide displays sequence homology to the nematode peptide, KPNFIRFamide (PF4). The physiological effects of KPSFVRFamide, PF4 and the chimeras, KPNFVRFamide and KPSFIRFamide, were measured on body wall muscle and the vagina vera of the parasitic nematode, Ascaris suum. KPNFVRFamide and KPNFIRFamide had Cl--dependent inhibitory activity on innervated and denervated muscle-preparations, whereas KPSFVRFamide and KPSFIRFamide did not elicit a detectable physiological effect. Although all 4 peptides had inhibitory effects on the vagina vera, KPSFVRFamide and KPSFIRFamide (threshold, greater than or equal to 0.1 mu M) were less potent than KPNFVRFamide and KPNFIRFamide (threshold, greater than or equal to 10 nM). (C) 1999 Academic Press.